Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya (APS)
The main purpose of this implementation science study is to find out if providing aPS at 18 different Ministry of Health (MOH) VCT clinics in Kenya works and is cost-effective. This would enable co-investigators in the Kenyan MOH to justify funding to scale-up these services.
The primary aim of the study is to find out whether providing aPS to sexual partners of newly tested HIV-infected individuals can result in more sexual partners getting counseled and HIV tested and linked to HIV care programs for initiation of ART if appropriate. The investigators hypothesize that aPS will increase rates of case-finding, linkages to care, and ART initiation and will not result in social harm.
The second aim is whether aPS is cost-effective in the Kenyan setting. The investigators will estimate how much it costs (when compared to standard methods) to identify and link HIV-infected persons into care. The investigators will also determine how successful aPS is at preventing future HIV transmission events and other outcomes associated with untreated HIV infection. The investigators hypothesize that HIV prevalence among partners in the immediate aPS arm will be high enough to make this approach cost-effective from the payer and societal perspective.
Finally, with the Kenya MOH, the investigators want to establish a nationwide monitoring system to evaluate why Kenyans are testing for HIV. In the future, when aPS is rolled out nationally, this will help Kenyan public health officials define the contribution of aPS to HIV case-finding. The investigators hypothesize that the proportion of newly tested HIV-infected individuals who report testing because of known exposure to a person with HIV will represent a significant proportion of new cases and the investigators will be able to identify places in Kenya where aPS will have the greatest impact on HIV treatment and prevention.
Studieoversikt
Detaljert beskrivelse
Diagnosing HIV soon after infection can benefit individuals and also has important public health benefits. It has been shown that starting antiretroviral therapy (ART) before HIV has progressed results in a better response to treatment and gives the person a better chance of long-term survival with HIV. Treating HIV can also reduce the risk that someone will transmit HIV to his or her sexual partners. The first step in achieving these individual and population level benefits is testing people for HIV. Unfortunately, in many parts of the world, including Kenya where we plan to conduct this study, many people are not tested regularly and do not know that they are infected. This study involves providing a public health service, notification of an exposure to a communicable disease and HIV testing, to sexual partners of those who test HIV-positive at voluntary counseling and testing (VCT) clinics in Kenya. Sexual partners are identified voluntarily by the person who tests at the VCT. A public health provider then goes to the home of the sexual partners to offer them HIV counseling and testing. This process is called provision of assisted partner services (aPS).
We propose a cluster randomized clinical trial which will be conducted in collaboration with the Kenya Ministry of Health (MOH) at 18 rural and urban voluntary counseling and testing (VCT) facilities across Kenya. Proposed activities will assess the effectiveness and cost-effectiveness of providing aPS, improve capacity for program implementation in Kenya, and lay the foundation for evaluating the program's impact at the national level.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Kiambu, Kenya
- Karuri VCT
-
Kiambu, Kenya
- Kiambu Hospital VCT
-
Kiambu, Kenya
- Kirwara VCT
-
Kisumu, Kenya
- Chulaimbo Health Centre
-
Kisumu, Kenya
- Joo Trh Vct
-
Kisumu, Kenya
- Kisumu East District Hospital
-
Kisumu, Kenya
- Kombewa VCT
-
Maseno, Kenya
- Maseno Mission
-
Nairobi, Kenya
- Baba Dogo VCT
-
Nairobi, Kenya
- Casino VCT
-
Nairobi, Kenya
- Huruma Lions
-
Nairobi, Kenya
- Kariobangi VCT
-
Nairobi, Kenya
- Kenyatta National Hospital (KNH) VCT
-
Nairobi, Kenya
- Mama Lucy Kibaki VCT
-
Nairobi, Kenya
- Mbagathi VCT
-
Nairobi, Kenya
- Pumwani VCT
-
Siaya, Kenya
- Abidha Health Centre
-
Siaya, Kenya
- Ongielo Health Centre
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Written informed consent is required of all participants. All participants must be 18 years or older.
- Index case participants must be HIV-seropositive, and willing and able to provide locator information for sexual partners in the past three years.
Exclusion Criteria:
- Index cases will be excluded from participation if they are pregnant, or have reported intimate partner violence during the last month. There is no exclusion criteria for partner participants.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Delayed aPS
|
|
|
Eksperimentell: Immediate aPS
|
Assisted-partner notification services (aPS) is a public health service which notifies the partners of those who test positive for a communicable disease of their exposure.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of partners testing for HIV
Tidsramme: 6 week period following index case enrollment
|
The number of partners of an index participant that were tested for HIV (offset will be the number of partners with locator information provided by the index participant).
|
6 week period following index case enrollment
|
|
Newly tested HIV-infected partners
Tidsramme: 6 week period following index case enrollment
|
The number of partners of an index participant identified as HIV-infected (offset will be the number of partners of that index participant who were HIV tested).
|
6 week period following index case enrollment
|
|
Number of partners linking to HIV care
Tidsramme: 6 week period following index case enrollment
|
The number of partners of an index participant who were linked to HIV care (offset will be the number of partners of an index participant identified as HIV-infected and analysis will be limited to index participants with at least one HIV-infected partner.)
|
6 week period following index case enrollment
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Incremental cost-effectiveness from payer and societal perspectives
Tidsramme: 6 week period following index case enrollment
|
6 week period following index case enrollment
|
|
Proportion of individuals with newly diagnosed HIV infection who report testing because of known exposure to a person with HIV
Tidsramme: 6 week period after index case enrollment
|
6 week period after index case enrollment
|
|
Costs of identifying >1 partner per index case
Tidsramme: 6 week period after index case enrollment
|
6 week period after index case enrollment
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Carey Farquhar, MD, MPH, University of Washington
- Studiestol: Peter Cherutich, MBChB, MPH, Kenya Ministry of Health
- Studiestol: Matthew Golden, MD, MPH, University of Washington
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Cherutich P, Golden MR, Wamuti B, Richardson BA, Asbjornsdottir KH, Otieno FA, Ng'ang'a A, Mutiti PM, Macharia P, Sambai B, Dunbar M, Bukusi D, Farquhar C; aPS Study Group. Assisted partner services for HIV in Kenya: a cluster randomised controlled trial. Lancet HIV. 2017 Feb;4(2):e74-e82. doi: 10.1016/S2352-3018(16)30214-4. Epub 2016 Nov 30.
- Wamuti BM, Erdman LK, Cherutich P, Golden M, Dunbar M, Bukusi D, Richardson B, Ng'ang'a A, Barnabas R, Mutiti PM, Macharia P, Jerop M, Otieno FA, Poole D, Farquhar C. Assisted partner notification services to augment HIV testing and linkage to care in Kenya: study protocol for a cluster randomized trial. Implement Sci. 2015 Feb 13;10:23. doi: 10.1186/s13012-015-0212-6.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 43628
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .